Drug intelligence / Profile preview

B-FORTE

Development stage: Unknown
Lead developer: Chumchons Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

B-FORTE is an approved oral vitamin supplement developed and marketed by Chumchons Pharmaceutical (Community Pharmacy PCL) in Thailand. It is a combination product containing three essential B vitamins: Thiamine (Vitamin B1), Pyridoxine (Vitamin B6), and Cyanocobalamin (Vitamin B12). The supplement is indicated for the treatment of Vitamin B deficiency and as a nutritional supplement to support metabolic processes and nerve function. As a small molecule combination, it works by replenishing depleted vitamin stores, thereby correcting deficiency-related symptoms such as neuropathy or metabolic disturbances.

Brand names: B-FORTEB-FORTE TABLET
Other names: Vitamin B1+B6+B12 supplementThiamine (B1) + Pyridoxine (B6) + Cyanocobalamin (B12)

Beyond the preview

Go deeper on B-FORTE.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on B-FORTE.

Explore the full profile